title: Why hasn't neuroprotection worked in Parkinson's disease?
authors.affiliation: University of Rochester Medical Center, Rochester, NY, USA. karl.kieburtz@ctcc.rochester.edu
authors.forename: Karl
authors.initials: K
authors.lastname: Kieburtz
authors.forename: Bernard
authors.initials: B
authors.lastname: Ravina
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D018696:Neuroprotective Agents